APO Research
Talk to an analyst

APO RESEARCH · REPORT

Complement Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Complement Inhibitors Industry Growth and Trends Forecast to 2032

28 December 2025101 pages

Choose your research edition.

Industry ResearchComplement Inhibitors Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Complement Inhibitors Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Complement Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Complement Inhibitors Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Complement Inhibitors Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Complement Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Complement Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Complement Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Complement Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Complement Inhibitors include Alexion Pharmaceuticals, Amgen, Apellis Pharmaceuticals, Astellas Pharma, CSL Behring, Pharming Healthcare, Regeneron Pharmaceuticals, Samsung Bioepis and UCB, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Complement Inhibitors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Complement Inhibitors market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Complement Inhibitors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Complement Inhibitors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Complement Inhibitors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Complement Inhibitors Market by Company

Alexion Pharmaceuticals

Amgen

Apellis Pharmaceuticals

Astellas Pharma

CSL Behring

Pharming Healthcare

Regeneron Pharmaceuticals

Samsung Bioepis

UCB

Roche

Novartis

Sanofi

Takeda

Complement Inhibitors Segment by Type

Complement Factor D Inhibitor

Complement Factor B Inhibitor

Complement C5 Inhibitors

Complement C3 Inhibitors

C1 Esterase Inhibitors

Complement Inhibitors Segment by Application

Geographic Atrophy (GA)

Atypical Hemolytic Uremic Syndrome (aHUS)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Others

Complement Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Complement Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Complement Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Complement Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Complement Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Complement Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Complement Factor D Inhibitor Table 2. Major Company of Complement Factor B Inhibitor Table 3. Major Company of Complement C5 Inhibitors Table 4. Major Company of Complement C3 Inhibitors Table 5. Major Company of C1 Esterase Inhibitors Table 6. Global Complement Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Complement Inhibitors Sales by Type (2021-2026) & (K Units) Table 8. Global Complement Inhibitors Sales Market Share in Volume by Type (2021-2026) Table 9. Global Complement Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 10. Global Complement Inhibitors Sales Market Share in Value by Type (2021-2026) Table 11. Global Complement Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 12. Global Complement Inhibitors Sales by Type (2027-2032) & (K Units) Table 13. Global Complement Inhibitors Sales Market Share in Volume by Type (2027-2032) Table 14. Global Complement Inhibitors Sales by Type (2027-2032) & (US$ Million) Table 15. Global Complement Inhibitors Sales Market Share in Value by Type (2027-2032) Table 16. Global Complement Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 17. North America Complement Inhibitors Sales by Type (2021-2026) & (K Units) Table 18. North America Complement Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Complement Inhibitors Sales by Type (2021-2026) & (K Units) Table 20. Europe Complement Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Complement Inhibitors Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Complement Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Complement Inhibitors Sales by Type (2021-2026) & (K Units) Table 24. Latin America Complement Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Complement Inhibitors Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Complement Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 27. Complement Inhibitors Industry Trends Table 28. Complement Inhibitors Industry Drivers Table 29. Complement Inhibitors Industry Opportunities and Challenges Table 30. Complement Inhibitors Industry Restraints Table 31. Global Complement Inhibitors Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Complement Inhibitors Revenue Market Share by Company (2021-2026) Table 33. Global Complement Inhibitors Sales by Company (2021-2026) & (K Units) Table 34. Global Complement Inhibitors Sales Share by Company (2021-2026) Table 35. Global Complement Inhibitors Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Complement Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Complement Inhibitors Major Company Production Sites and Headquarters Table 38. Global Complement Inhibitors Company, Product Type & Application Table 39. Global Complement Inhibitors Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Complement Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Complement Inhibitors Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Complement Inhibitors Sales by Region (2021-2026) & (K Units) Table 44. Global Complement Inhibitors Sales Market Share in Volume by Region (2021-2026) Table 45. Global Complement Inhibitors Sales by Region (2021-2026) & (US$ Million) Table 46. Global Complement Inhibitors Sales Market Share in Value by Region (2021-2026) Table 47. Global Complement Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Complement Inhibitors Sales by Region (2027-2032) & (K Units) Table 49. Global Complement Inhibitors Sales Market Share in Volume by Region (2027-2032) Table 50. Global Complement Inhibitors Sales by Region (2027-2032) & (US$ Million) Table 51. Global Complement Inhibitors Sales Market Share in Value by Region (2027-2032) Table 52. Global Complement Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Complement Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Complement Inhibitors Sales by Application (2021-2026) & (K Units) Table 55. Global Complement Inhibitors Sales Market Share in Volume by Application (2021-2026) Table 56. Global Complement Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 57. Global Complement Inhibitors Sales Market Share in Value by Application (2021-2026) Table 58. Global Complement Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 59. Global Complement Inhibitors Sales by Application (2027-2032) & (K Units) Table 60. Global Complement Inhibitors Sales Market Share in Volume by Application (2027-2032) Table 61. Global Complement Inhibitors Sales by Application (2027-2032) & (US$ Million) Table 62. Global Complement Inhibitors Sales Market Share in Value by Application (2027-2032) Table 63. Global Complement Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 64. North America Complement Inhibitors Sales by Application (2021-2026) & (K Units) Table 65. North America Complement Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Complement Inhibitors Sales by Application (2021-2026) & (K Units) Table 67. Europe Complement Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Complement Inhibitors Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Complement Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Complement Inhibitors Sales by Application (2021-2026) & (K Units) Table 71. Latin America Complement Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Complement Inhibitors Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Complement Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 74. Alexion Pharmaceuticals Company Information Table 75. Alexion Pharmaceuticals Business Overview Table 76. Alexion Pharmaceuticals Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Alexion Pharmaceuticals Complement Inhibitors Product Portfolio Table 78. Alexion Pharmaceuticals Recent Development Table 79. Amgen Company Information Table 80. Amgen Business Overview Table 81. Amgen Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Amgen Complement Inhibitors Product Portfolio Table 83. Amgen Recent Development Table 84. Apellis Pharmaceuticals Company Information Table 85. Apellis Pharmaceuticals Business Overview Table 86. Apellis Pharmaceuticals Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Apellis Pharmaceuticals Complement Inhibitors Product Portfolio Table 88. Apellis Pharmaceuticals Recent Development Table 89. Astellas Pharma Company Information Table 90. Astellas Pharma Business Overview Table 91. Astellas Pharma Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Astellas Pharma Complement Inhibitors Product Portfolio Table 93. Astellas Pharma Recent Development Table 94. CSL Behring Company Information Table 95. CSL Behring Business Overview Table 96. CSL Behring Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. CSL Behring Complement Inhibitors Product Portfolio Table 98. CSL Behring Recent Development Table 99. Pharming Healthcare Company Information Table 100. Pharming Healthcare Business Overview Table 101. Pharming Healthcare Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Pharming Healthcare Complement Inhibitors Product Portfolio Table 103. Pharming Healthcare Recent Development Table 104. Regeneron Pharmaceuticals Company Information Table 105. Regeneron Pharmaceuticals Business Overview Table 106. Regeneron Pharmaceuticals Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Regeneron Pharmaceuticals Complement Inhibitors Product Portfolio Table 108. Regeneron Pharmaceuticals Recent Development Table 109. Samsung Bioepis Company Information Table 110. Samsung Bioepis Business Overview Table 111. Samsung Bioepis Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Samsung Bioepis Complement Inhibitors Product Portfolio Table 113. Samsung Bioepis Recent Development Table 114. UCB Company Information Table 115. UCB Business Overview Table 116. UCB Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. UCB Complement Inhibitors Product Portfolio Table 118. UCB Recent Development Table 119. Roche Company Information Table 120. Roche Business Overview Table 121. Roche Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Roche Complement Inhibitors Product Portfolio Table 123. Roche Recent Development Table 124. Novartis Company Information Table 125. Novartis Business Overview Table 126. Novartis Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Novartis Complement Inhibitors Product Portfolio Table 128. Novartis Recent Development Table 129. Sanofi Company Information Table 130. Sanofi Business Overview Table 131. Sanofi Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Sanofi Complement Inhibitors Product Portfolio Table 133. Sanofi Recent Development Table 134. Takeda Company Information Table 135. Takeda Business Overview Table 136. Takeda Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Takeda Complement Inhibitors Product Portfolio Table 138. Takeda Recent Development Table 139. North America Complement Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. North America Complement Inhibitors Sales by Country (2021-2026) & (K Units) Table 141. North America Complement Inhibitors Sales Market Share by Country (2021-2026) Table 142. North America Complement Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 143. North America Complement Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 144. North America Complement Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. North America Complement Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 146. North America Complement Inhibitors Market Share by Country (2021-2026) Table 147. North America Complement Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. North America Complement Inhibitors Market Share Forecast by Country (2027-2032) Table 149. Europe Complement Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. Europe Complement Inhibitors Sales by Country (2021-2026) & (K Units) Table 151. Europe Complement Inhibitors Sales Market Share by Country (2021-2026) Table 152. Europe Complement Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 153. Europe Complement Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 154. Europe Complement Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Europe Complement Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 156. Europe Complement Inhibitors Market Share by Country (2021-2026) Table 157. Europe Complement Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Europe Complement Inhibitors Market Share Forecast by Country (2027-2032) Table 159. Asia-Pacific Complement Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 160. Asia-Pacific Complement Inhibitors Sales by Country (2021-2026) & (K Units) Table 161. Asia-Pacific Complement Inhibitors Sales Market Share by Country (2021-2026) Table 162. Asia-Pacific Complement Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 163. Asia-Pacific Complement Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 164. Asia-Pacific Complement Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Asia-Pacific Complement Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 166. Asia-Pacific Complement Inhibitors Market Share by Country (2021-2026) Table 167. Asia-Pacific Complement Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Asia-Pacific Complement Inhibitors Market Share Forecast by Country (2027-2032) Table 169. Latin America Complement Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 170. Latin America Complement Inhibitors Sales by Country (2021-2026) & (K Units) Table 171. Latin America Complement Inhibitors Sales Market Share by Country (2021-2026) Table 172. Latin America Complement Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 173. Latin America Complement Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 174. Latin America Complement Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Latin America Complement Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 176. Latin America Complement Inhibitors Market Share by Country (2021-2026) Table 177. Latin America Complement Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Latin America Complement Inhibitors Market Share Forecast by Country (2027-2032) Table 179. Middle East and Africa Complement Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 180. Middle East and Africa Complement Inhibitors Sales by Country (2021-2026) & (K Units) Table 181. Middle East and Africa Complement Inhibitors Sales Market Share by Country (2021-2026) Table 182. Middle East and Africa Complement Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 183. Middle East and Africa Complement Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 184. Middle East and Africa Complement Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 185. Middle East and Africa Complement Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 186. Middle East and Africa Complement Inhibitors Market Share by Country (2021-2026) Table 187. Middle East and Africa Complement Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 188. Middle East and Africa Complement Inhibitors Market Share Forecast by Country (2027-2032) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Complement Inhibitors Distributors List Table 192. Complement Inhibitors Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Complement Inhibitors Image Figure 2. Global Complement Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Complement Inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global Complement Inhibitors Sales (2021-2032) & (K Units) Figure 5. Complement Factor D Inhibitor Image Figure 6. Global Complement Factor D Inhibitor Sales YoY Growth (2021-2032) & (K Units) Figure 7. Complement Factor B Inhibitor Image Figure 8. Global Complement Factor B Inhibitor Sales YoY Growth (2021-2032) & (K Units) Figure 9. Complement C5 Inhibitors Image Figure 10. Global Complement C5 Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 11. Complement C3 Inhibitors Image Figure 12. Global Complement C3 Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 13. C1 Esterase Inhibitors Image Figure 14. Global C1 Esterase Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Complement Inhibitors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Complement Inhibitors Market Share by Type 2025 VS 2032 Figure 17. North America Complement Inhibitors Sales Market Share in Volume by Type in 2025 Figure 18. North America Complement Inhibitors Sales Market Share in Value by Type in 2025 Figure 19. Europe Complement Inhibitors Sales Market Share in Volume by Type in 2025 Figure 20. Europe Complement Inhibitors Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Complement Inhibitors Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Complement Inhibitors Sales Market Share in Value by Type in 2025 Figure 23. Latin America Complement Inhibitors Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Complement Inhibitors Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Complement Inhibitors Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Complement Inhibitors Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Complement Inhibitors Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Geographic Atrophy (GA) Image Figure 30. Global Geographic Atrophy (GA) Sales YoY Growth (2021-2032) & (K Units) Figure 31. Atypical Hemolytic Uremic Syndrome (aHUS) Image Figure 32. Global Atypical Hemolytic Uremic Syndrome (aHUS) Sales YoY Growth (2021-2032) & (K Units) Figure 33. Paroxysmal Nocturnal Hemoglobinuria (PNH) Image Figure 34. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Sales YoY Growth (2021-2032) & (K Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Complement Inhibitors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Complement Inhibitors Market Share by Application 2025 VS 2032 Figure 39. North America Complement Inhibitors Sales Market Share in Volume by Application in 2025 Figure 40. North America Complement Inhibitors Sales Market Share in Value by Application in 2025 Figure 41. Europe Complement Inhibitors Sales Market Share in Volume by Application in 2025 Figure 42. Europe Complement Inhibitors Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Complement Inhibitors Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Complement Inhibitors Sales Market Share in Value by Application in 2025 Figure 45. Latin America Complement Inhibitors Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Complement Inhibitors Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Complement Inhibitors Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Complement Inhibitors Sales Market Share in Value by Application in 2025 Figure 49. North America Complement Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Complement Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Complement Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Complement Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Complement Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Complement Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Complement Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Complement Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Complement Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Complement Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Complement Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Complement Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Complement Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Complement Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Complement Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Complement Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Complement Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Complement Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Complement Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Complement Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Complement Inhibitors Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Complement Inhibitors Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Complement Factor D Inhibitor
  • Complement Factor B Inhibitor
  • Complement C5 Inhibitors
  • Complement C3 Inhibitors
  • C1 Esterase Inhibitors
Applications
  • Geographic Atrophy (GA)
  • Atypical Hemolytic Uremic Syndrome (aHUS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Others
Companies covered
  • Alexion Pharmaceuticals
  • Amgen
  • Apellis Pharmaceuticals
  • Astellas Pharma
  • CSL Behring
  • Pharming Healthcare
  • Regeneron Pharmaceuticals
  • Samsung Bioepis
  • UCB
  • Roche
  • Novartis
  • Sanofi
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Complement Inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Complement Inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Complement Inhibitors Market by Type
  6. 1.3.1 Complement Factor D Inhibitor
  7. 1.3.2 Complement Factor B Inhibitor
  8. 1.3.3 Complement C5 Inhibitors
  9. 1.3.4 Complement C3 Inhibitors
  10. 1.3.5 C1 Esterase Inhibitors
  11. 1.4 Global Complement Inhibitors Market Size by Type
  12. 1.4.1 Global Complement Inhibitors Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Complement Inhibitors Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Complement Inhibitors Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Complement Inhibitors Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Complement Inhibitors Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Complement Inhibitors Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Complement Inhibitors Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Complement Inhibitors Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Complement Inhibitors Industry Trends
  2. 2.2 Complement Inhibitors Industry Drivers
  3. 2.3 Complement Inhibitors Industry Opportunities and Challenges
  4. 2.4 Complement Inhibitors Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Complement Inhibitors Revenue (2021-2026)
  2. 3.2 Global Top Players by Complement Inhibitors Sales (2021-2026)
  3. 3.3 Global Top Players by Complement Inhibitors Price (2021-2026)
  4. 3.4 Global Complement Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Complement Inhibitors Major Company Production Sites & Headquarters
  6. 3.6 Global Complement Inhibitors Company, Product Type & Application
  7. 3.7 Global Complement Inhibitors Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Complement Inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Complement Inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Complement Inhibitors Tier 1, Tier 2, and Tier 3
4 Complement Inhibitors Regional Status and Outlook
  1. 4.1 Global Complement Inhibitors Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Complement Inhibitors Historic Market Size by Region
  3. 4.2.1 Global Complement Inhibitors Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Complement Inhibitors Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Complement Inhibitors Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Complement Inhibitors Forecasted Market Size by Region
  7. 4.3.1 Global Complement Inhibitors Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Complement Inhibitors Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Complement Inhibitors Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Complement Inhibitors by Application
  1. 5.1 Complement Inhibitors Market by Application
  2. 5.1.1 Geographic Atrophy (GA)
  3. 5.1.2 Atypical Hemolytic Uremic Syndrome (aHUS)
  4. 5.1.3 Paroxysmal Nocturnal Hemoglobinuria (PNH)
  5. 5.1.4 Others
  6. 5.2 Global Complement Inhibitors Market Size by Application
  7. 5.2.1 Global Complement Inhibitors Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Complement Inhibitors Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Complement Inhibitors Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Complement Inhibitors Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Complement Inhibitors Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Complement Inhibitors Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Complement Inhibitors Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Complement Inhibitors Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alexion Pharmaceuticals
  2. 6.1.1 Alexion Pharmaceuticals Company Information
  3. 6.1.2 Alexion Pharmaceuticals Business Overview
  4. 6.1.3 Alexion Pharmaceuticals Complement Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alexion Pharmaceuticals Complement Inhibitors Product Portfolio
  6. 6.1.5 Alexion Pharmaceuticals Recent Developments
  7. 6.2 Amgen
  8. 6.2.1 Amgen Company Information
  9. 6.2.2 Amgen Business Overview
  10. 6.2.3 Amgen Complement Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amgen Complement Inhibitors Product Portfolio
  12. 6.2.5 Amgen Recent Developments
  13. 6.3 Apellis Pharmaceuticals
  14. 6.3.1 Apellis Pharmaceuticals Company Information
  15. 6.3.2 Apellis Pharmaceuticals Business Overview
  16. 6.3.3 Apellis Pharmaceuticals Complement Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Apellis Pharmaceuticals Complement Inhibitors Product Portfolio
  18. 6.3.5 Apellis Pharmaceuticals Recent Developments
  19. 6.4 Astellas Pharma
  20. 6.4.1 Astellas Pharma Company Information
  21. 6.4.2 Astellas Pharma Business Overview
  22. 6.4.3 Astellas Pharma Complement Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Astellas Pharma Complement Inhibitors Product Portfolio
  24. 6.4.5 Astellas Pharma Recent Developments
  25. 6.5 CSL Behring
  26. 6.5.1 CSL Behring Company Information
  27. 6.5.2 CSL Behring Business Overview
  28. 6.5.3 CSL Behring Complement Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CSL Behring Complement Inhibitors Product Portfolio
  30. 6.5.5 CSL Behring Recent Developments
  31. 6.6 Pharming Healthcare
  32. 6.6.1 Pharming Healthcare Company Information
  33. 6.6.2 Pharming Healthcare Business Overview
  34. 6.6.3 Pharming Healthcare Complement Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pharming Healthcare Complement Inhibitors Product Portfolio
  36. 6.6.5 Pharming Healthcare Recent Developments
  37. 6.7 Regeneron Pharmaceuticals
  38. 6.7.1 Regeneron Pharmaceuticals Company Information
  39. 6.7.2 Regeneron Pharmaceuticals Business Overview
  40. 6.7.3 Regeneron Pharmaceuticals Complement Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Regeneron Pharmaceuticals Complement Inhibitors Product Portfolio
  42. 6.7.5 Regeneron Pharmaceuticals Recent Developments
  43. 6.8 Samsung Bioepis
  44. 6.8.1 Samsung Bioepis Company Information
  45. 6.8.2 Samsung Bioepis Business Overview
  46. 6.8.3 Samsung Bioepis Complement Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Samsung Bioepis Complement Inhibitors Product Portfolio
  48. 6.8.5 Samsung Bioepis Recent Developments
  49. 6.9 UCB
  50. 6.9.1 UCB Company Information
  51. 6.9.2 UCB Business Overview
  52. 6.9.3 UCB Complement Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 UCB Complement Inhibitors Product Portfolio
  54. 6.9.5 UCB Recent Developments
  55. 6.10 Roche
  56. 6.10.1 Roche Company Information
  57. 6.10.2 Roche Business Overview
  58. 6.10.3 Roche Complement Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Roche Complement Inhibitors Product Portfolio
  60. 6.10.5 Roche Recent Developments
  61. 6.11 Novartis
  62. 6.11.1 Novartis Company Information
  63. 6.11.2 Novartis Business Overview
  64. 6.11.3 Novartis Complement Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Novartis Complement Inhibitors Product Portfolio
  66. 6.11.5 Novartis Recent Developments
  67. 6.12 Sanofi
  68. 6.12.1 Sanofi Company Information
  69. 6.12.2 Sanofi Business Overview
  70. 6.12.3 Sanofi Complement Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sanofi Complement Inhibitors Product Portfolio
  72. 6.12.5 Sanofi Recent Developments
  73. 6.13 Takeda
  74. 6.13.1 Takeda Company Information
  75. 6.13.2 Takeda Business Overview
  76. 6.13.3 Takeda Complement Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Takeda Complement Inhibitors Product Portfolio
  78. 6.13.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America Complement Inhibitors Sales by Country
  2. 7.1.1 North America Complement Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Complement Inhibitors Sales by Country (2021-2026)
  4. 7.1.3 North America Complement Inhibitors Sales Forecast by Country (2027-2032)
  5. 7.2 North America Complement Inhibitors Market Size by Country
  6. 7.2.1 North America Complement Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Complement Inhibitors Market Size by Country (2021-2026)
  8. 7.2.3 North America Complement Inhibitors Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Complement Inhibitors Sales by Country
  2. 8.1.1 Europe Complement Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Complement Inhibitors Sales by Country (2021-2026)
  4. 8.1.3 Europe Complement Inhibitors Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Complement Inhibitors Market Size by Country
  6. 8.2.1 Europe Complement Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Complement Inhibitors Market Size by Country (2021-2026)
  8. 8.2.3 Europe Complement Inhibitors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Complement Inhibitors Sales by Country
  2. 9.1.1 Asia-Pacific Complement Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Complement Inhibitors Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Complement Inhibitors Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Complement Inhibitors Market Size by Country
  6. 9.2.1 Asia-Pacific Complement Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Complement Inhibitors Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Complement Inhibitors Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Complement Inhibitors Sales by Country
  2. 10.1.1 South America Complement Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Complement Inhibitors Sales by Country (2021-2026)
  4. 10.1.3 South America Complement Inhibitors Sales Forecast by Country (2027-2032)
  5. 10.2 South America Complement Inhibitors Market Size by Country
  6. 10.2.1 South America Complement Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Complement Inhibitors Market Size by Country (2021-2026)
  8. 10.2.3 South America Complement Inhibitors Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Complement Inhibitors Sales by Country
  2. 11.1.1 Middle East and Africa Complement Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Complement Inhibitors Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Complement Inhibitors Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Complement Inhibitors Market Size by Country
  6. 11.2.1 Middle East and Africa Complement Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Complement Inhibitors Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Complement Inhibitors Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Complement Inhibitors Value Chain Analysis
  2. 12.1.1 Complement Inhibitors Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Complement Inhibitors Production Mode & Process
  7. 12.2 Complement Inhibitors Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Complement Inhibitors Distributors
  10. 12.2.3 Complement Inhibitors Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst